NASDAQ: LEGN
Legend Biotech Corp Stock Ownership - Who owns Legend Biotech?

Insider buying vs selling

Have Legend Biotech Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick John CaseyDirector2026-06-306,000$14.80
$88.80kSell
Ying HuangChief Executive Officer2026-06-255,566$14.78
$82.27kSell
Ying HuangChief Executive Officer2026-03-259,936$8.77
$87.14kSell

1 of 1

LEGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LEGN insiders and whales buy or sell their stock.

LEGN Shareholders

What type of owners hold Legend Biotech Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC6.92%25,696,740$489.52MInstitution
Deerfield Management Company LP2.07%7,687,638$146.45MInstitution
Suvretta Capital Management LLC2.04%7,581,029$144.42MInstitution
Hhlr Advisors Ltd1.61%5,984,550$114.01MInstitution
Westfield Capital Management Co LP1.55%5,763,475$109.79MInstitution
Blackrock Inc1.26%4,684,543$89.24MInstitution
Point72 Asset Management LP1.05%3,886,017$74.03MInstitution
First Beijing Investment Ltd0.62%2,296,335$43.75MInstitution
Artisan Partners Limited Partnership0.61%2,254,488$42.95MInstitution
Two Sigma Investments LP0.51%1,890,396$36.01MInstitution

1 of 3

LEGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LEGN25.86%0.15%Net SellingNet Selling
GPCR31.31%10.35%Net SellingNet Buying
ARQT77.49%22.51%Net SellingNet Selling
TLX0.76%7.56%Net Buying
RCUS67.93%32.07%Net SellingNet Selling

Legend Biotech Stock Ownership FAQ

Who owns Legend Biotech?

Legend Biotech (NASDAQ: LEGN) is owned by 25.86% institutional shareholders, 0.15% Legend Biotech insiders, and 73.99% retail investors. Fmr LLC is the largest individual Legend Biotech shareholder, owning 25.70M shares representing 6.92% of the company. Fmr LLC's Legend Biotech shares are currently valued at $476.67M.

If you're new to stock investing, here's how to buy Legend Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.